The catalysts worth watching this month

We currently track 0 upcoming events, 0 of them flagged must-watch. The highest-significance entries are below, free — with links to check each one at the primary source.

No upcoming catalysts are currently published.

The calendar archive has previous months while the next one is prepared.

The dates are free. The analysis is the product.

Anyone can find a PDUFA date. What loses people money is not knowing what the trial has to show, or which risk nobody put in the press release. Pro adds three layers to every entry above.

What success has to prove

The primary endpoint, the effect size that would count as clinically meaningful, and the safety bar — stated before the readout, not after.

What failure looks like

Missed endpoints, weak durability, subgroup problems, and the label-limiting safety signals that turn a "positive" trial into a bad outcome.

Financing and dilution risk

Cash runway against the catalyst date, and whether a positive result is likely to be followed by a raise anyway.

See the format applied end to end in the sample Pro memo.

Get the weekly briefing

Every Sunday: the catalysts landing that week and what would count as a miss. No card required, unsubscribe any time.

Free weekly biotech briefing. No spam. We only use this address for the briefing. By subscribing, you agree to our Privacy Policy and Terms.

ClinicalInvestor Pro

Know what to watch before the readout hits.

Built for investors who want a repeatable catalyst checklist, not another noisy stock feed. $29/month, cancel any time. Annual billing is $249/year through Stripe.

Educational use only. ClinicalInvestor does not provide personalized financial advice or recommendations to buy or sell securities. Catalyst entries are compiled with AI assistance and edited under our editorial policy; confirm dates at the primary source before acting.